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Abstract:  In this work, we present the synthesis of a copper complex 
of 1-benzyl-2-[(5-methyl-isoxazol-3-yl)methyl]-benzimidazole, by using 
simultaneously UV spectrophotometry and X-ray diffraction. It has been 
possible for us to highlight an original oxidation of benzylbenzimidazole 
group in such complex leading to ketone. A kinetic study carried out by UV 
spectrophotometry shows well that the oxidation reaction proceeds 
according to the first-order kinetic law: K = 9.4×10
-4 s
-1 and t½ = 12.4 min. 
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INTRODUCTION 
 
Due to the vast applications that could be found in the coordination complex with 
benzimidazole, last decades, the synthesis of this compound aroused the interest of 
scientific research [1-10].  
Indeed, it was shown that such compounds intervened at complex fields as varied in 
organic synthesis (catalysts [11, 12], renewable energies [13, 14] and complexant 
properties [15]). Thus, in the last years, much of the works concerning the synthesis of 
this coordination complex were brought back in literature showing the molecules with 
very varied structures [16-19].  
Moreover, the synthesis of heterocyclic systems containing the benzimidazole motif 
often aroused the passion for researchers. Indeed, the studies showed that such 
compounds are largely implied in several fields such as pharmacology area: they have 
shown antibacterial [20], anticancerous [21, 22] and antiulcerous [23, 24] properties. 
In a similar way, in this work, we endeavoured to prepare a new complex of 
coordination likely to find important application thereafter.  
 
 
EXPERIMENTAL 
 
Melting points were taken using an electrothermal machine. The infrared spectra (IR) 
were carried out with Perkin-Elmer 1760x spectrometer. Single crystal X-ray diffraction 
data were collected on a SMART Apex II 4K CCD diffractometer (Bruker AXS).This 
instrument uses graphite monochromatic MoKα radiation (l = 0.71073 Å) and was 
operating at  50kV × 30 mA. A green single crystal of complex 4 was analyzed at room 
temperature. The program Saint V7.34A [25] was used to extract the reflections from 
collected frames and to correct the corresponding intensities for Lorentz and 
polarization effects. The data were then corrected for absorption (SADABS [26] 
2008/1). The study of systematic absences was performed using Bruker’s Xprep [27] 
program and confirmed the monoclinic space group P21/c. The crystal structure was 
solved by direct methods (Shelxs97 [28]). Refinements were carried out by full matrix 
least squares method with the Shelxl97 [28] program. Hydrogen atoms were placed in 
theoretical positions and refined riding on their parent atoms. 
To a solution of ligand 3 (1.65×10
-4 mol) in methanol (4 mL) we added a quantity of 
copper perchlorate corresponding to stoechiometry (1/1). After completion of the 
reaction the complex was dried under reduced pressure. 
 
 
RESULTS AND DISCUSSIONS  
 
In a previous work we have showed that 1,5-benzodiazepines constitute an interesting 
precursors in the synthesis of recoveral  heterocyclic systems [29-31]. In particular the 
1,5-benzodiazepin-2-one  1  reacted with hydroxylamine hydrochloride in methanol 
giving rise to compound 2 presenting a benzimidazole and an isoxazole motifs. The 
alkylation reaction carried out on compound 2 by benzyl chloride using liquid-solid 
phase transfer catalysis [32-36] led to awaited compound with good yields (Figure 1).  
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Figure 1. Synthesis of compound 3 from 1,5-benzodiazepin-2-one 
 
Reaction of complexation 
 
The ligand 3 prepared and also characterized, it was interesting to be able to study its 
potentialities of complexation. Indeed, the reaction of compound 3 with hexahydrated 
copper perchlorate, at ambient temperature, in methalonic medium gave rise to complex 
4 (Figure 2). 
 
EtOH
3
+                     Cu(ClO4)2, 6H2O
N
O CH3
N
N
Ph
4
H3C
Cu
N
O CH3
N
N
O
O
O
H3C
O
O
 
N
O
N
N
Ph
CH3
O
N N
N
O
CH3
Ph
NN
N
O
H3C
Ph
Cu
Ph
 
Figure 2. Complexation of ligand 3 with hexahydrated copper perchlorate 
 
The structural study by X-ray diffraction (Figure 3) carried out on complex 4, emerged 
certain important points: initially, the complex 4 arises as a binuclear in which each 
pentacoordinnated copper atom can be described as deformed pyramid, with an 
environment defined by three atoms of nitrogen and two atoms of oxygen. ATTAR, KANDRI RODI, BENCHIDMI, HAOUDI, CAPET, ROLANDO and ESSASSI 
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Figure 3. ORTEP diagram of compound 4 with numbering scheme 
 
The crystal data and the experimental conditions have been assembled in Table 1. 
The compound 4 crystallizes in monoclinic system. The determination of the structure 
and refinement are treated in P21/c  space  group.  The  structure  parameters  are:                 
a = 11.9675(2) Å; b = 19.5247(5) Å; c = 17.0103(4) Å; α = 90°; β = 108°13’; δ = 90°. 
The structure resolution revealed a perchlorate molecule and a water molecule. 
Unfortunately, the parameters for those molecules were very difficult to refine because 
of disorder. Therefore, we have used the program SQUEEZE from PLATON [37] to 
suppress this solvent contribution. 
The oxygen atoms implied in this coordination come from oxidation of methylene group 
out of carbonyl group. In this reaction, the methanol plays at the same time the role of 
solvent and as nucleophilic agent. 
The oxidation of methylene group as revealed by X-ray diffraction can be interpreted by 
cycloaddition [2+2] of oxygen molecule on the enaminic tautomer form 3a. The 
rearrangement of intermediate dioxetane led to α-hydroxycetone which through 
dehydratation process provides the compound 5 (Figure 4). 
A study by infrared spectroscopy of complexation reaction shows that the νC=O vibration 
band at 1692 cm
-1 appears only after a metal addition. This confirms well that the 
methylene bridge oxidation reaction is closely related to the complexation. 
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Table 1. Crystal data and experimental conditions for compound 4 
Formula C78H66Cu2N12O10 
Formula weight  1458.51 
Crystal system  Monoclinic 
Crystal size (mm
3) 0.49×0.45×0.42 
Space group  P21/c 
a (Å)  11.9663 (6) 
b (Å)  19.5120 (9) 
c (Å)  16.9908 (8) 
β (°)  107.959 (2) 
V (Å
3) 3773.8  (3) 
Z 2 
Density (g/cm
3) 1.284 
F (000)  1512 
Μ (MoKα) (mm
-1)  0.63 
Diffractometer  Bruker AXS Smart APEX II 
T (K)  295(2) 
Scan mode  ω –scans and φ -scans 
θ max (°)  33.2 
Measured reflection  132508 
Independent reflection  14300 
Rint 0.047 
Absorption correction  Multi-scan (sadabs 2008/ 1 Bruker AXS) 
Reflection parameters  463 
Reflection used for reference [I > 2σ (I)]  9455 
H atoms  Prameters constrained 
R [F
2 > 2σ(F
2)] 0.043 
wR (F
2) 0.123 
W 1/[  σ
2(Fo
2)+(0.0677P)
2] where P = (Fo2+2Fc
2)/3 
Goodness of fit  1.04 
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Figure 4. Formation of compound 5 ATTAR, KANDRI RODI, BENCHIDMI, HAOUDI, CAPET, ROLANDO and ESSASSI 
 
                                                                                                                             St. Cerc. St. CICBIA  2012 13 (1)  24 
Kinetic studies of oxidation reaction 
  
The oxidation phenomenon revealed by IR is also confirmed by UV spectrophotometry. 
However, we noted considerable reaction acceleration. The optical density OD = f( λ) 
for φ = 1 curve of absorption is recorded every 10 minutes (Table 2 and Figure 5).  
 
Table 2. Parameters of oxidation reaction 
  Time, min  Height of the peak (H), mm  H∞ - Ht Log(H∞ - Ht) 
1 00
  8 82  1.91 
2 10  46  44  1.64 
3 20  68  22  1.34 
4 30  78  12  1.07 
5 40
  82 8  0.90 
6 50  85  5  0.69 
7 60
  87 3  0.48 
8 70
  88.5 1.5  0.18 
9 80
  89 1  0.00 
10 90  90  0  - 
 
 
Figure 5. Oxidation of ligand 3 with hexahydrated copper perchlorate 
 
 
CONCLUSION 
 
In this work, the study by infra-red spectroscopy enabled us to highlight, initially, an 
original oxidation of the methylene bridge out of carbonyl during the complexation of  
Cu
2+ ion by 1-benzyl-2[5-(methylisoxazol-3-yl)-methyl] benzimidazole in acetonitrile. 
This oxidation phenomenon could be explained by the capturing character of methylene 
group. 
It is worth noting that the compound 4 presents an original structure. It is a complex of 
ML2 type. The first ligand involves nitrogenous atoms of benzimidazole and of 
pyrazole. The second ligand engages in complexation reaction nitrogenous atom of 
benzimidazole and hemiacetale  oxygen formed by the action of methanol over the 
formed ketone. Moreover, it was possible for us, in this type of reactions, to trap a DEMONSTRATION OF HETEROARYLMETHANE OXIDATION IN A BENZIMIDAZOLE DERIVATIVE WITH THE 
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hemiacetal. It is well known that hemi-acetals are generally unstable and react with 
another alcohol molecule ending up with correspondent acetals.  
The kinetic study of oxidation reaction carried out by UV spectrophotometry detected a 
clear acceleration in these conditions compared to the infra-red one. This difference of 
reactivity between UV and IR shows well the photochemical character of reaction.  
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